News
Alpha Modus Holdings, Inc. (Nasdaq: AMOD) (“Company”) announced today that its wholly owned subsidiary, Alpha Modus, Corp. ("Alpha Modus"), a leader in AI-driven retail technology, filed a patent ...
AstraZeneca's Alexion Pharmaceuticals was sued in Massachusetts federal court on Wednesday in a class action complaint ...
Zacks Investment Research on MSN3d
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?Amedisys (AMED) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a ...
RBC Capital analyst Ben Hendrix maintained a Buy rating on Amedisys (AMED – Research Report) yesterday and set a price target of $100.00.Stay ...
UnitedHealth, Amedisys and antitrust regulators will have a magistrate judge’s help in hashing out a solution to the DOJ’s ...
The United States Justice Department’s lawsuit to block UnitedHealth Group’s (UHG’s) $3.3 billion acquisition of Amedisys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback